Literature DB >> 2919198

Submandibular gland resection and bilateral parotid duct ligation as a management for chronic drooling in cerebral palsy.

S R Brundage1, W D Moore.   

Abstract

The control of chronic drooling in cerebral palsy has been difficult in the past. Previous methods to control drooling include the Wilkie procedure, which diverts the salivary flow from the parotid glands by means of surgically created tunnels to the tonsillar fossa, along with submandibular gland resection. An alternative is submandibular gland resection with bilateral parotid duct ligation. Previous published studies using this method have resulted in good to excellent results, but population sizes were felt to be too small to be conclusive. Since 1979, a total of 58 patients have been treated by parotid duct ligation with submandibular gland resection, and 86 percent have shown good to excellent results. These results compare favorably with those published by Wilkie. Also, parotid duct ligation is technically easier, associated with less postoperative morbidity, and has shown a decreased duration of hospitalization compared to parotid duct transposition.

Entities:  

Mesh:

Year:  1989        PMID: 2919198     DOI: 10.1097/00006534-198903000-00005

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Nonsurgical treatment of drooling in a patient with closed head injury and severe dysarthria.

Authors:  J P Dworkin; J C Nadal
Journal:  Dysphagia       Date:  1991       Impact factor: 3.438

2.  Deterioration of feeding behavior following surgical treatment of drooling.

Authors:  R D Stevenson; J H Allaire; P A Blasco
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

Review 3.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.